Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06561672

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery

Status
Enrolling By Invitation
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
102 (estimated)
Sponsor
Zagazig University · Other Government
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Implementation of enhanced recovery in day case surgeries using either preemptive intravenous paracetamol plus tramadol or preemptive intravenous fentanyl.

Detailed description

after being informed about the study and potential risks. All patients giving written consent will be randomized by double blind manner into two equal groups (T group and F group). Using computer generated randomization table; each group consists of 51 patients:Group (T) (n=51): Patients will receive preemptive intravenous infusion of tramadol plus paracetamol . Group (F) (n=51): Patients will receive preemptive intravenous fentanyl.

Conditions

Interventions

TypeNameDescription
DRUGtramadol plus paracetamolIntravenous infusion of 15mg/kg paracetamol together with 1mg/kg tramadol will be started and to be finished before starting of induction of anesthesia (induction agent will be propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)
DRUGFentanylIntravenous injection of 1.5 microgram/kg fentanyl will be given to the patient followed by induction agents (propofol 2mg/kg).
DRUGpropofol and muscle relaxant (cisatracurium)propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)
DRUGPropofolpropofol 2mg/kg

Timeline

Start date
2024-09-01
Primary completion
2025-03-20
Completion
2025-06-20
First posted
2024-08-20
Last updated
2024-08-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06561672. Inclusion in this directory is not an endorsement.